Partners:





High Throughput Screening

ITI has developed a proprietary high-throughput screening system to identify molecules that inhibit nuclear entry of many viruses. The basis of this screen will broaden ITI’s ability to take advantage of its nuclear entry intellectual property as a platform technology. This ELISA-based assay is adaptable to a Biomek® FX Laboratory Automated Workstation which will provide ITI with the ability to evaluate thousands of compounds per week.


Back to top